Literature DB >> 17850911

Glycoprotein gene relocation in rabies virus.

Xianfu Wu1, Charles E Rupprecht.   

Abstract

Unlike vesicular stomatitis virus, rabies virus glycoprotein gene has not been successfully relocated closer to promoter-proximal regions by reverse genetics. Here we describe an efficient system for the Evelyn-Rokitnicki-Abelseth (ERA) rabies virus with the glycoprotein gene switched with the matrix protein gene, creating a reshuffled virus ERAgm (gene order N-P-G-M-L). With the aid of an autogene plasmid, the T7 RNA polymerase containing a nuclear location signal from the SV40 large T antigen facilitated virus recovery. The rearranged ERAgm rabies virus replicated as well as the parental ERA (gene order N-P-M-G-L) virus, reaching 10(9) ffu/ml in infected BSR cells. The altered glycoprotein gene position in viral genome presented an alternative way to study the pathogenicity of rabies virus. This also provides a potential novel method for rabies vaccine development.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17850911     DOI: 10.1016/j.virusres.2007.07.018

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  18 in total

1.  Newcastle disease virus-vectored rabies vaccine is safe, highly immunogenic, and provides long-lasting protection in dogs and cats.

Authors:  Jinying Ge; Xijun Wang; Lihong Tao; Zhiyuan Wen; Na Feng; Songtao Yang; Xianzhu Xia; Chinglai Yang; Hualan Chen; Zhigao Bu
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

2.  Using rabies virus vaccine strain SRV9 as viral vector to express exogenous gene.

Authors:  Hualei Wang; Hongli Jin; Na Feng; Xuexing Zheng; Ling Li; Yinglin Qi; Meng Liang; Yongkun Zhao; Tiecheng Wang; Yuwei Gao; Changchun Tu; Ningyi Jin; Songtao Yang; Xianzhu Xia
Journal:  Virus Genes       Date:  2015-02-28       Impact factor: 2.332

3.  Gene order rearrangement of the M gene in the rabies virus leads to slower replication.

Authors:  Xian-Feng Yang; Jiao-Jiao Peng; Hong-Ru Liang; You-Tian Yang; Yi-Fei Wang; Xiao-Wei Wu; Jiao-Jiao Pan; Yong-Wen Luo; Xiao-Feng Guo
Journal:  Virusdisease       Date:  2014-06-07

4.  Rabies vaccine preserved by vaporization is thermostable and immunogenic.

Authors:  Todd G Smith; Marina Siirin; Xianfu Wu; Cathleen A Hanlon; Victor Bronshtein
Journal:  Vaccine       Date:  2015-03-23       Impact factor: 3.641

5.  Rescue of a wild-type rabies virus from cloned cDNA and assessment of the proliferative capacity of recombinant viruses.

Authors:  Qin Tian; Yifei Wang; Qiong Zhang; Jun Luo; Mingzhu Mei; Yongwen Luo; Xiaofeng Guo
Journal:  Virus Genes       Date:  2017-04-26       Impact factor: 2.332

6.  Arenavirus Genome Rearrangement for the Development of Live Attenuated Vaccines.

Authors:  Benson Yee Hin Cheng; Emilio Ortiz-Riaño; Juan Carlos de la Torre; Luis Martínez-Sobrido
Journal:  J Virol       Date:  2015-05-13       Impact factor: 5.103

7.  New rabies virus variants for monitoring and manipulating activity and gene expression in defined neural circuits.

Authors:  Fumitaka Osakada; Takuma Mori; Ali H Cetin; James H Marshel; Beatriz Virgen; Edward M Callaway
Journal:  Neuron       Date:  2011-08-25       Impact factor: 17.173

8.  Generation of a More Immunogenic Measles Vaccine by Increasing Its Hemagglutinin Expression.

Authors:  Emily Julik; Jorge Reyes-Del Valle
Journal:  J Virol       Date:  2016-05-12       Impact factor: 5.103

9.  Assessment of the immunogenicity of rabies vaccine preserved by vaporization and delivered to the duodenal mucosa of gray foxes (Urocyon cinereoargenteus).

Authors:  Todd G Smith; Xianfu Wu; James A Ellison; Ashutosh Wadhwa; Richard Franka; Gregory L Langham; Brianna L Skinner; Cathleen A Hanlon; Victor L Bronshtein
Journal:  Am J Vet Res       Date:  2017-06       Impact factor: 1.156

Review 10.  The cell biology of rabies virus: using stealth to reach the brain.

Authors:  Matthias J Schnell; James P McGettigan; Christoph Wirblich; Amy Papaneri
Journal:  Nat Rev Microbiol       Date:  2010-01       Impact factor: 60.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.